Beclometasone inhaler Drug Interactions
172Total Interactions
126Severe
24Moderate
0Mild
| Drug | Severity | Summary |
|---|---|---|
| Aceclofenac | SEVERE | Aceclofenac increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufa... |
| Amifampridine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Amiodarone | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Amisulpride | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Anagrelide | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Apalutamide | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Apomorphine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Aripiprazole | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Arsenic trioxide | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Artemether | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Artenimol | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Atezolizumab | SEVERE | Beclometasone might affect the efficacy of Atezolizumab. Manufacturer advises use with caution or... |
| Atracurium | SEVERE | Beclometasone is predicted to decrease the effects of Atracurium. Manufacturer makes no recommend... |
| Bacillus Calmette-Guérin vaccine | SEVERE | Bacillus Calmette-Guérin vaccine is predicted to increase the risk of generalised infection (poss... |
| Bedaquiline | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Benzydamine | SEVERE | Benzydamine increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufa... |
| Bosutinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Bromfenac | SEVERE | Bromfenac increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Cabozantinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Celecoxib | SEVERE | Celecoxib increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Ceritinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Chikungunya vaccine (live) | SEVERE | Chikungunya vaccine (live) is predicted to increase the risk of generalised infection (possibly l... |
| Chlorpromazine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Cholera vaccine (live) | SEVERE | Cholera vaccine (live) is predicted to increase the risk of generalised infection (possibly life-... |
| Cisatracurium | SEVERE | Beclometasone is predicted to decrease the effects of Cisatracurium. Manufacturer makes no recomm... |
| Citalopram | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Clomipramine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Crizotinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Dasatinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Deferasirox | SEVERE | Beclometasone is predicted to increase the risk of gastrointestinal bleeding when given with Defe... |
| Delamanid | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Dengue vaccine | SEVERE | Dengue vaccine is predicted to increase the risk of generalised infection (possibly life-threaten... |
| Desflurane | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Dexketoprofen | SEVERE | Dexketoprofen increases the risk of gastrointestinal bleeding when given with Beclometasone. Manu... |
| Diclofenac | SEVERE | Diclofenac increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufac... |
| Digoxin | SEVERE | Beclometasone is predicted to increase the risk of Digoxin toxicity when given with Digoxin. Manu... |
| Dinutuximab | SEVERE | Beclometasone is predicted to increase the risk of immunosuppression when given with Dinutuximab.... |
| Disopyramide | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Dronedarone | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Droperidol | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Efavirenz | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Encorafenib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Entrectinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Eribulin | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Erlotinib | SEVERE | Erlotinib is predicted to increase the risk of gastrointestinal perforation when given with Beclo... |
| Erythromycin | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Escitalopram | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Etodolac | SEVERE | Etodolac increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufactu... |
| Etoricoxib | SEVERE | Etoricoxib increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufac... |
| Fluconazole | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Flurbiprofen | SEVERE | Flurbiprofen increases the risk of gastrointestinal bleeding when given with Beclometasone. Manuf... |
| Glasdegib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Haloperidol | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Hydroxychloroquine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Hydroxyzine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Ibuprofen | SEVERE | Ibuprofen increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Indometacin | SEVERE | Indometacin increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufa... |
| Influenza vaccine (live) | SEVERE | Influenza vaccine (live) is predicted to increase the risk of generalised infection (possibly lif... |
| Inotuzumab ozogamicin | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Ipilimumab | SEVERE | Beclometasone might affects the efficacy of Ipilimumab. Manufacturer advises use with caution or ... |
| Isoflurane | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Ivosidenib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Ketoprofen | SEVERE | Ketoprofen increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufac... |
| Ketorolac | SEVERE | Ketorolac increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Lapatinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Lenacapavir | SEVERE | Lenacapavir is predicted to increase the concentration of Beclometasone. Manufacturer advises adj... |
| Lenvatinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Levomepromazine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Measles, mumps and rubella vaccine | SEVERE | Measles, mumps and rubella vaccine is predicted to increase the risk of generalised infection (po... |
| Mefenamic acid | SEVERE | Mefenamic acid increases the risk of gastrointestinal bleeding when given with Beclometasone. Man... |
| Meloxicam | SEVERE | Meloxicam increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Methadone | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Mifamurtide | SEVERE | Beclometasone is predicted to decrease the efficacy of Mifamurtide. Manufacturer advises avoid. |
| Mivacurium | SEVERE | Beclometasone is predicted to decrease the effects of Mivacurium. Manufacturer makes no recommend... |
| Moxifloxacin | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Nabumetone | SEVERE | Nabumetone increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufac... |
| Naproxen | SEVERE | Naproxen increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufactu... |
| Natalizumab | SEVERE | Beclometasone might increase the risk of generalised infection (possibly life-threatening) when g... |
| Nepafenac | SEVERE | Nepafenac increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Nicorandil | SEVERE | Beclometasone increases the risk of gastrointestinal perforation when given with Nicorandil. Manu... |
| Nilotinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Nivolumab | SEVERE | Beclometasone might affects the efficacy of Nivolumab. Manufacturer advises use with caution or a... |
| Ondansetron | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Osilodrostat | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Osimertinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Paliperidone | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Pancuronium | SEVERE | Beclometasone is predicted to decrease the effects of Pancuronium. Manufacturer makes no recommen... |
| Panobinostat | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Parecoxib | SEVERE | Parecoxib increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Pasireotide | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Pazopanib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Pembrolizumab | SEVERE | Beclometasone might affect the efficacy of Pembrolizumab. Manufacturer advises use with caution o... |
| Phenazone | SEVERE | Phenazone increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Pimozide | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Piroxicam | SEVERE | Piroxicam increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Promethazine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Quinine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Quizartinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Ranolazine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Ribociclib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Rocuronium | SEVERE | Beclometasone is predicted to decrease the effects of Rocuronium. Manufacturer makes no recommend... |
| Rotavirus vaccine | SEVERE | Rotavirus vaccine is predicted to increase the risk of generalised infection (possibly life-threa... |
| Selpercatinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Serplulimab | SEVERE | Beclometasone might affect the efficacy of Serplulimab. Manufacturer advises use with caution or ... |
| Sevoflurane | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Sorafenib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Sotalol | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Sulindac | SEVERE | Sulindac increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufactu... |
| Sunitinib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Suxamethonium | SEVERE | Beclometasone is predicted to decrease the effects of Suxamethonium. Manufacturer makes no recomm... |
| Tenoxicam | SEVERE | Tenoxicam increases the risk of gastrointestinal bleeding when given with Beclometasone. Manufact... |
| Tetrabenazine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Tiaprofenic acid | SEVERE | Tiaprofenic acid increases the risk of gastrointestinal bleeding when given with Beclometasone. M... |
| Tolfenamic acid | SEVERE | Tolfenamic acid increases the risk of gastrointestinal bleeding when given with Beclometasone. Ma... |
| Tolterodine | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Toremifene | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Typhoid vaccine (live) | SEVERE | Typhoid vaccine (live) is predicted to increase the risk of generalised infection (possibly life-... |
| Vandetanib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Vardenafil | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Varicella-zoster vaccine | SEVERE | Varicella-zoster vaccine is predicted to increase the risk of generalised infection (possibly lif... |
| Vecuronium | SEVERE | Beclometasone is predicted to decrease the effects of Vecuronium. Manufacturer makes no recommend... |
| Vemurafenib | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Vernakalant | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Voclosporin | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Voriconazole | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Yellow fever vaccine | SEVERE | Yellow fever vaccine is predicted to increase the risk of generalised infection (possibly life-th... |
| Acenocoumarol | MODERATE | Beclometasone is predicted to increase the effects of Acenocoumarol. Manufacturer advises monitor... |
| Aspirin | MODERATE | Beclometasone is predicted to decrease the concentration of Aspirin (high-dose) and Aspirin (high... |
| Atazanavir | MODERATE | Atazanavir is predicted to increase the exposure to Beclometasone (risk with beclometasone is lik... |
| Choline salicylate | MODERATE | Beclometasone is predicted to decrease the concentration of Choline salicylate. Manufacturer make... |
| Clarithromycin | MODERATE | Clarithromycin is predicted to increase the exposure to Beclometasone (risk with beclometasone is... |
| Cobicistat | MODERATE | Cobicistat is predicted to increase the exposure to Beclometasone (risk with beclometasone is lik... |
| Darunavir | MODERATE | Darunavir is predicted to increase the exposure to Beclometasone (risk with beclometasone is like... |
| Fosamprenavir | MODERATE | Fosamprenavir is predicted to increase the exposure to Beclometasone (risk with beclometasone is ... |
| Glycerol phenylbutyrate | MODERATE | Beclometasone potentially opposes the effects of Glycerol phenylbutyrate. Manufacturer advises mo... |
| Idelalisib | MODERATE | Idelalisib is predicted to increase the exposure to Beclometasone (risk with beclometasone is lik... |
| Itraconazole | MODERATE | Itraconazole is predicted to increase the exposure to Beclometasone (risk with beclometasone is l... |
| Ketoconazole | MODERATE | Ketoconazole is predicted to increase the exposure to Beclometasone (risk with beclometasone is l... |
| Lopinavir | MODERATE | Lopinavir is predicted to increase the exposure to Beclometasone (risk with beclometasone is like... |
| Mifepristone | MODERATE | Mifepristone is predicted to decrease the efficacy of Beclometasone. Manufacturer advises use wit... |
| Nirmatrelvir | MODERATE | Nirmatrelvir boosted with ritonavir is predicted to increase the concentration of Beclometasone (... |
| Phenindione | MODERATE | Beclometasone is predicted to increase the effects of Phenindione. Manufacturer advises monitor INR. |
| Posaconazole | MODERATE | Posaconazole is predicted to increase the exposure to Beclometasone (risk with beclometasone is l... |
| Ritonavir | MODERATE | Ritonavir is predicted to increase the exposure to Beclometasone (risk with beclometasone is like... |
| Sodium phenylbutyrate | MODERATE | Beclometasone potentially decreases the effects of Sodium phenylbutyrate. Manufacturer advises mo... |
| Somapacitan | MODERATE | Beclometasone might decrease the efficacy of Somapacitan. Manufacturer advises monitor and adjust... |
| Somatrogon | MODERATE | Beclometasone might decrease the efficacy of Somatrogon. Manufacturer advises monitor and adjust ... |
| Somatropin | MODERATE | Beclometasone is predicted to decrease the effects of Somatropin. Manufacturer advises monitor. |
| Tucatinib | MODERATE | Tucatinib is predicted to increase the exposure to Beclometasone (risk with beclometasone is like... |
| Warfarin | MODERATE | Beclometasone is predicted to increase the effects of Warfarin. Manufacturer advises monitor INR. |
| Aminophylline | LOW | Both Beclometasone and Aminophylline can increase the risk of hypokalaemia. |
| Amphotericin B | LOW | Both Beclometasone and Amphotericin B can increase the risk of hypokalaemia. |
| Bendroflumethiazide | LOW | Both Beclometasone and Bendroflumethiazide can increase the risk of hypokalaemia. |
| Bumetanide | LOW | Both Beclometasone and Bumetanide can increase the risk of hypokalaemia. |
| Chlorothiazide | LOW | Both Beclometasone and Chlorothiazide can increase the risk of hypokalaemia. |
| Chlortalidone | LOW | Both Beclometasone and Chlortalidone can increase the risk of hypokalaemia. |
| Formoterol | LOW | Both Beclometasone and Formoterol can increase the risk of hypokalaemia. |
| Furosemide | LOW | Both Beclometasone and Furosemide can increase the risk of hypokalaemia. |
| Hydrochlorothiazide | LOW | Both Beclometasone and Hydrochlorothiazide can increase the risk of hypokalaemia. |
| Hydroflumethiazide | LOW | Both Beclometasone and Hydroflumethiazide can increase the risk of hypokalaemia. |
| Indacaterol | LOW | Both Beclometasone and Indacaterol can increase the risk of hypokalaemia. |
| Indapamide | LOW | Both Beclometasone and Indapamide can increase the risk of hypokalaemia. |
| Isoprenaline | LOW | Both Beclometasone and Isoprenaline can increase the risk of hypokalaemia. |
| Metolazone | LOW | Both Beclometasone and Metolazone can increase the risk of hypokalaemia. |
| Olodaterol | LOW | Both Beclometasone and Olodaterol can increase the risk of hypokalaemia. |
| Salbutamol | LOW | Both Beclometasone and Salbutamol can increase the risk of hypokalaemia. |
| Salmeterol | LOW | Both Beclometasone and Salmeterol can increase the risk of hypokalaemia. |
| Terbutaline | LOW | Both Beclometasone and Terbutaline can increase the risk of hypokalaemia. |
| Theophylline | LOW | Both Beclometasone and Theophylline can increase the risk of hypokalaemia. |
| Torasemide | LOW | Both Beclometasone and Torasemide can increase the risk of hypokalaemia. |
| Vilanterol | LOW | Both Beclometasone and Vilanterol can increase the risk of hypokalaemia. |
| Xipamide | LOW | Both Beclometasone and Xipamide can increase the risk of hypokalaemia. |
Check Beclometasone inhaler against your patient's full medication list
InteractRx checks all drug combinations at once — built for GP surgery pharmacists.
Use the Free Checker